Neoadjuvant Guides d'étude, Notes de cours & Résumés

APHON Principles of Chemo and Biotherapy, Top Questions and answers, 100% Accurate. Verified. Biotherapy - Targeted anticancer agents also known as biological response modifiers (BRM) Tyrosine kinase inhibitors (TKIs) are what class - Biotherapy Monoclonal antibodies (MoAbs) are what class - Biotherapy Define pharmacokinetics - Study of drug absorption, metabolism, and excretion Define pharmacodynamics - The concentration of the drug in the body and how it produces a response ...

Which of the following is a permissible disclosure of confidential patient information from the cancer registry? a. to a facility not involved with the patient's care b. to the pt c. to another registry for f/u purposes d. to the pt's attorney To another registry for f/u purposes What is a source of ca incidence & survival data from pop-based ca registries covering ~28% of US pop? a. ACoS CoC b. CDC NPCR c. NAACCR d. NCI SEER program NCI SEER program Medical data that are...

Hormone Therapy correct answer: Used to treat hormone sensitive cancers. Stops or reduces the body's ability to produce hormones. Also, substitutes chemically similar agents for the active hormones that cannot be used by the tumor. Ex: SERMS, AIs, Progesterones, Antiandrogens, LHRH. Immunomodulatory Drugs correct answer: Inhibit anti-inflammatory cytokines and exert anti-angiogenic properties. Ex: Revlimid, Thaudomide Adjuvant Therapy correct answer: The use of additional cancer treatm...

A comprehensive geriatric assessment (CGA) is a multidisciplinary evaluation to assess life expectancy and risk of morbidity and mortality in the older patient. This assessment tool would evaluate and include the following areas: functional status, socioeconomic issues, psychosocial Neoadjuvant therapy does not increase survival when compared to adjuvant therapy. It only changes the timing of treatment and can change surgical options if the tumor is shrunk enough. If this occurs, the patient may...

Neoadjuvant therapy does not increase survival when compared to adjuvant therapy. It only changes the timing of treatment and can change surgical options if the tumor is shrunk enough. If this occurs, the patient may only require a lumpectomy plus radiation therapy instead of needing a mastectomy - CORRECT ANS Main benefit of neoadjuvant chemotherapy (breast cancer patient) A comprehensive geriatric assessment (CGA) is a multidisciplinary evaluation to assess life expectancy and risk of mo...

Neoadjuvant therapy does not increase survival when compared to adjuvant therapy. It only changes the timing of treatment and can change surgical options if the tumor is shrunk enough. If this occurs, the patient may only require a lumpectomy plus radiation therapy instead of needing a mastectomy Main benefit of neoadjuvant chemotherapy (breast cancer patient) A comprehensive geriatric assessment (CGA) is a multidisciplinary evaluation to assess life expectancy and risk of morbidity and ...

ONS Chemotherapy Immunotherapy Certificate 2023 Questions and Answers 3 major phases of cell division: - ANSWER - Interphase Mitotic phase Cytokinesis 3 steps of interphase: - ANSWER - First growth phase (G1) Synthesis phase (S phase) Second growth phase (G2) 4 phases of mitosis: - ANSWER - Prophase Metaphase Anaphase Telophase Innate immunity: - ANSWER - Non-specific response, either: 1. Barrier (skin, mucous membranes, flora of skin/gut) 2. Cellular components (phagocytes,...

High-Yield and Frequently Missed ABSITE questions well answered 2023Breast: What is presentation, treatment, prognosis for intraductal papilloma? - correct answer presents with bleeding/bloody nipple discharge (most common cause), usually benign, biopsy/resect via major duct excision Breast: What are contraindications to BCT (lumpectomy) in stage I breast cancer (and what specifically is not)? - correct answer 1) prior irradiation; 2) pos margins; 3) inflammatory; 4) pregnancy (unless 3...

Neoadjuvant therapy does not increase survival when compared to adjuvant therapy. It only changes the timing of treatment and can change surgical options if the tumor is shrunk enough. If this occurs, the patient may only require a lumpectomy plus radiation therapy instead of needing a mastectomy - correct answerMain benefit of neoadjuvant chemotherapy (breast cancer patient) A comprehensive geriatric assessment (CGA) is a multidisciplinary evaluation to assess life expectancy and risk of mor...

Neoadjuvant therapy does not increase survival when compared to adjuvant therapy. It only changes the timing of treatment and can change surgical options if the tumor is shrunk enough. If this occurs, the patient may only require a lumpectomy plus radiation therapy instead of needing a mastectomy - Correct answer-Main benefit of neoadjuvant chemotherapy (breast cancer patient) A comprehensive geriatric assessment (CGA) is a multidisciplinary evaluation to assess life expectancy and risk of...